Sign Up to like & get
recommendations!
0
Published in 2022 at "Immunopharmacology and immunotoxicology"
DOI: 10.1080/08923973.2022.2062380
Abstract: Background: The overall survival of melanoma patients remains poor despite advancements in surgical treatment and targeted therapies. Therefore, there is a need to develop new therapeutic strategies for melanoma. 2-methoxyestradiol (2-ME) is a major metabolite…
read more here.
Keywords:
tumor effects;
anti tumor;
methoxyestradiol inhibits;
melanoma ... See more keywords